BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,708,000 | +7.0% | 6,045,000 | +9.3% | 0.19% | +13.9% |
| Q1 2017 | $6,268,000 | -1.5% | 5,530,000 | -2.1% | 0.17% | -5.7% |
| Q4 2016 | $6,364,000 | +14.2% | 5,650,000 | +21.5% | 0.18% | +4.1% |
| Q3 2016 | $5,575,000 | +33.5% | 4,650,000 | +24.0% | 0.17% | +26.1% |
| Q2 2016 | $4,176,000 | -3.6% | 3,750,000 | 0.0% | 0.13% | -2.9% |
| Q1 2016 | $4,332,000 | -10.2% | 3,750,000 | 0.0% | 0.14% | +7.8% |
| Q4 2015 | $4,826,000 | +64.0% | 3,750,000 | +66.7% | 0.13% | +75.3% |
| Q3 2015 | $2,942,000 | -49.6% | 2,250,000 | -40.0% | 0.07% | -42.1% |
| Q2 2015 | $5,838,000 | – | 3,750,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|